We are live on
!
Find out more
WA1
Wimmer Associates 1 Portfolio holdings
AUM
$205M
1-Year Est. Return
21.23%
This Fund
S&P 500
This Quarter
Est. Return
+4.56%
1 Year Est. Return
+21.23%
3 Year Est. Return
+69.43%
5 Year Est. Return
+91.58%
10 Year Est. Return
+307.32%
AUM
$109M
AUM Growth
-$14K
(-0.01%)
Cap. Flow
-$4.32M
Cap. Flow
% of AUM
-3.98%
Top 10 Holdings %
Top 10 Hldgs %
25.09%
Holding
113
New
4
Increased
20
Reduced
58
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nucor
NUE
|
+$1.33M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$768K |
| 3 |
DuPont de Nemours
DD
|
+$463K |
| 4 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$349K |
| 5 |
Alibaba
BABA
|
+$227K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.47M |
| 2 |
AGN
Allergan plc
AGN
|
+$626K |
| 3 |
Wells Fargo
WFC
|
+$508K |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$430K |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$377K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.23% |
| 2 | Technology | 13.01% |
| 3 | Industrials | 11.81% |
| 4 | Financials | 9.82% |
| 5 | Consumer Staples | 8.69% |
Similar funds
UWM
LFA
TCM
PKC
WCM
LWM
KFA
TFM
Wimmer Associates 1's Q3 2017 Portfolio in Review
As of Q3 2017, Wimmer Associates 1 held 113 positions worth $109M, down 0.01% from $109M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Wimmer Associates 1 withdrew a net $4.32M in Q3 2017, closing 6 positions and reducing 58 holdings. Its most notable exit was AstraZeneca, an estimated $1.47M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 16% a quarter earlier, followed by Technology and Industrials.
Against the trend, Wimmer Associates 1 opened a new position in Nucor worth $1.32M.
- Wimmer Associates 1's largest Q3 2017 buy was Nucor: 23,615 shares worth $1.32M.
- Wimmer Associates 1 added most to Vanguard FTSE Developed Markets ETF in Q3 2017, an estimated $768K increase.
- Wimmer Associates 1's biggest Q3 2017 reduction was Wells Fargo, cutting an estimated $508K.
- Wimmer Associates 1 fully exited AstraZeneca in Q3 2017, selling an estimated $1.47M.
- Wimmer Associates 1's ten largest holdings make up 25% of its $109M portfolio in Q3 2017.
- Wimmer Associates 1 opened 4 new positions and closed 6 in Q3 2017.
- Wimmer Associates 1's portfolio value fell 0.01% quarter-over-quarter to $109M.
Based on Wimmer Associates 1's 13F filing for Q3 2017, filed 14 Nov 2017.